10x Genomics (NASDAQ:TXG) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...

A member of the UCSC Braingeneers group talks with symposium attendees about their research with brain organoids. Photo Credit: Anusha Ravishankar. Twenty-five years ago, UC Santa Cruz played a ...

Ratings for 10x Genomics (NASDAQ:TXG) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

Many of today's most advanced tools in medicine are not designed for the real-world clinical environments where most of the global population receives care. Vignesh Bageerathan, a genomics innovator ...

This workshop explored current and potential future applications for AI in genomics and precision health along the continuum from translational research to clinical applications. A planning committee ...

Recognized neonatologist and payer-strategy leader joins GeneDx to expand earlier diagnosis and establish genomics as a standard of care across healthcare GeneDx (Nasdaq: WGS), a leader in delivering ...

The past decade ushered in a surge of discovery in the field of human genetics — and simultaneously, more genetic technologies made their way out of the lab and into the consumer marketplace. This ...